# A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

> clinical trial · VERIFIED · 2026-07-01

Status: RECRUITING · Sponsor: Neuron23 Inc. · Condition: Parkinson Disease

- Company: Neuron23 Inc.
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT06680830

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.